Renaissance Lakewood Begins U.S. Manufacturing of FDA-Approved neffy®, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis

Renaissance Lakewood, LLC (“Renaissance”), a leading global contract development and manufacturing organization (“CDMO”) is proud...

October 04, 2024 | Friday | News
Recipharm and Exela Pharma Forge Strategic Alliance to Boost U.S. Sterile Manufacturing with 100+ Million Units Capacity

Sterile manufacturing capability in the US with over 100 million readily-available units (including vials and Pre-Filled Syringes – PFS) Extensi...

October 04, 2024 | Friday | News
Abzena's AbZelectPRO™ Platform Reduces Cell Line Development Timelines by 30%, Boosts Protein Production for Biopharma

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced that its mammalian cell line development platform, ...

September 27, 2024 | Friday | News
Ascend Strengthens Global Gene Therapy Support with New Multi-Million Dollar Investments in Technology and Flexible Capacity

Continued Investment in Technology & Flexible Capacity, Including New Fill/Finish Capabilities, Fortify the Global Gene Therapy Support Offer at Ascend...

September 25, 2024 | Wednesday | News
Agarose Bead Technologies Completes Major Expansion of Spanish Facility to Meet Global Demand for Pharmaceutical Resins

Agarose Bead Technologies (ABT), a leading manufacturer of high-quality agarose resins, proudly announces the completion of a major expansion at its faci...

September 25, 2024 | Wednesday | News
Shuttle Pharmaceuticals Expands Phase 2 Glioblastoma Trial with Two Additional Sites

Shuttle Pharmaceuticals Holdings, a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients tr...

September 17, 2024 | Tuesday | News
Symbiosis Pharmaceutical Expands Manufacturing Capacity with New Facility in Stirling

Symbiosis Pharmaceutical Services Ltd (Symbiosis), a rapidly growing sterile biopharmaceutical Contract Manufacturing Organisation (CMO) announces the pu...

September 09, 2024 | Monday | News
Hongene Biotech and ReciBioPharm Forge Strategic Alliance to Enhance Gene Editing Drug Manufacturing

Hongene Biotech Corporation, a global leader in nucleic acid manufacturing, and ReciBioPharm, a leading advanced therapeutics CDMO services provider, hav...

September 09, 2024 | Monday | News
Enzene Biosciences Appoints Norm Stoffregen as SVP and Head of New $50 Million Biologics Manufacturing Facility in New Jersey

Enzene Biosciences, a fully integrated CDMO with services spanning discovery, development and commercial supply, today announced the appointment of Norm St...

September 04, 2024 | Wednesday | News
Renaissance Lakewood Expands CDMO Operations with New State-of-the-Art Warehouse Facility

Renaissance Lakewood, LLC (“Renaissance”), a leading pharmaceutical contract development and manufacturing organization (CDMO),  announc...

September 04, 2024 | Wednesday | News
Avance Clinical Expands Global Site Partnership Network with 2,000 North American Sites, Enhancing Biotech Clinical Development

Avance Clinical, the award-winning market-leading CRO for biotechs, announced today that 2,000 clinical sites across North America had joined the Avance ...

September 02, 2024 | Monday | News
360biolabs Celebrates the Grand Opening of New State-of-the-Art Facility in Melbourne, Victoria

With great excitement and pride, 360biolabs is thrilled to announce the official opening of its new purpose-built facility, strategically located within ...

August 22, 2024 | Thursday | News
Emergent BioSolutions Completes $30 Million Sale of Baltimore-Camden Facility to Bora Pharmaceuticals

Emergent BioSolutions Inc.  announced it has completed the sale of its drug product facility in Baltimore-Camden to an affiliate of B...

August 21, 2024 | Wednesday | News
Merck Life Science India and Aragen Life Sciences Sign Landmark MoU to Accelerate mAb Manufacturing and Innovation

Merck Life Science in India  announced the signing of a Memorandum of Understanding (MoU) with Aragen Life Sciences, a leading provider of R&D a...

August 09, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close